FEMA549793
CETP Recombinant Rabbit Monoclonal Antibody (2F1), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FEMA549793-Each-of-1 | In Stock | ₹ 37,202.00 |
FEMA549793 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,202.00
GST (18%): ₹ 6,696.36
Total Price: ₹ 43,898.36
Antigen
CETP
Classification
Recombinant Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide, pH 7.4
Gene Accession No.
P11597
Gene Symbols
CETP
Immunogen
A synthesized peptide derived from human CETP
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Applications
ELISA, Immunohistochemistry (Paraffin)
Clone
2F1
Conjugate
Unconjugated
Gene
CETP
Gene Alias
BPI fold containing family F, BPIFF, CETP, Cholesteryl ester transfer protein, cholesteryl ester transfer protein plasma, cholesteryl ester transfer protein, plasma, HDLCQ10, Lipid transfer protein I
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
1071
Content And Storage
-20°C or -80°C if preferred
Isotype
IgG
Related Products
Description
- It has been proposed that high density lipoproteins (HDLs) function jointly with lecithin:cholesterol acyltransferase and CETP to facilitate cholesterol transport from tissues to the liver
- This mechanism, referred to as reverse cholesterol transport, is physiologically important because it maintains systemic cholesterol levels
- CETP is responsible for neutral lipid transfer activity in plasma in numerous species
- Since CETP is able to accelerate specifically the exchange of lipid components between pro- and anti-atherogenic lipoprotein fractions, it may be a key determinant of the global atherogenicity of the plasma lipoprotein profile and arises as a possible target in atherosclerosis prevention
- CETP has an important role in reverse cholesterol transport and shaping and affecting the composition of plasma lipoproteins
- In general elevated levels of CETP have been associated with increased risk of coronary heart disease.